Group One Trading’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,400
| Closed | -$65.8K | – | 8366 |
|
|
2022
Q4 | $65.8K | Sell |
4,400
-8,500
| -66% | -$118K | ﹤0.01% | 4793 |
|
|
2022
Q3 | $106K | Sell |
12,900
-2,200
| -15% | -$16.9K | ﹤0.01% | 4730 |
|
|
2022
Q2 | $99K | Buy |
15,100
+1,200
| +9% | +$5.81K | ﹤0.01% | 5003 |
|
|
2022
Q1 | $78K | Sell |
13,900
-65,800
| -83% | -$271K | ﹤0.01% | 5739 |
|
|
2021
Q4 | $374K | Buy |
79,700
+11,500
| +17% | +$71.3K | ﹤0.01% | 4444 |
|
|
2021
Q3 | $421K | Sell |
68,200
-11,400
| -14% | -$68.2K | ﹤0.01% | 4391 |
|
|
2021
Q2 | $525K | Buy |
79,600
+40,300
| +103% | +$278K | ﹤0.01% | 4176 |
|
|
2021
Q1 | $288K | Sell |
39,300
-20,000
| -34% | -$173K | ﹤0.01% | 4627 |
|
|
2020
Q4 | $342K | Buy |
59,300
+29,900
| +102% | +$171K | ﹤0.01% | 3612 |
|
|
2020
Q3 | $175K | Sell |
29,400
-15,600
| -35% | -$77.2K | ﹤0.01% | 3763 |
|
|
2020
Q2 | $232K | Buy |
45,000
+36,300
| +417% | +$229K | ﹤0.01% | 3262 |
|
|
2020
Q1 | $31K | Sell |
8,700
-12,580
| -59% | -$62.4K | ﹤0.01% | 4015 |
|
|
2019
Q4 | $133K | Sell |
21,280
-29,850
| -58% | -$220K | ﹤0.01% | 3462 |
|
|
2019
Q3 | $432K | Sell |
51,130
-5,400
| -10% | -$40.2K | ﹤0.01% | 2455 |
|
|
2019
Q2 | $381K | Buy |
56,530
+7,160
| +15% | +$61.3K | ﹤0.01% | 2383 |
|
|
2019
Q1 | $405K | Sell |
49,370
-12,400
| -20% | -$128K | ﹤0.01% | 2113 |
|
|
2018
Q4 | $988K | Buy |
61,770
+18,860
| +44% | +$415K | 0.01% | 1525 |
|
|
2018
Q3 | $1.42M | Buy |
42,910
+2,890
| +7% | +$74.3K | 0.01% | 1419 |
|
|
2018
Q2 | $904K | Buy |
40,020
+35,300
| +748% | +$837K | 0.01% | 1820 |
|
|
2018
Q1 | $137K | Sell |
4,720
-10,780
| -70% | -$315K | ﹤0.01% | 3046 |
|
|
2017
Q4 | $432K | Buy |
15,500
+300
| +2% | +$9.31K | ﹤0.01% | 2366 |
|
|
2017
Q3 | $555K | Buy |
15,200
+15,100
| +15,100% | +$467K | 0.01% | 1985 |
|
|
2017
Q2 | $2K | Buy |
+100
| New | +$787 | ﹤0.01% | 4602 |
|
|
2013
Q3 | – | Sell |
-17,610
| Closed | -$440K | – | 5773 |
|
|
2013
Q2 | $440K | Buy |
+17,610
| New | +$753K | 0.01% | 1457 |
|
Group One Trading's AVEO Position: Q1 2023 in Review
Group One Trading sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 34,258 shares — an estimated $512K sold.
Group One Trading first reported a position in AVEO in Q2 2013 and held it in 19 quarters. The position peaked at $566K in Q2 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Group One Trading reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Group One Trading sold 34,258 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $512K.
- Group One Trading first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 19 quarters.
- Group One Trading's AVEO Pharmaceuticals, Inc. position peaked at $566K in Q2 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Group One Trading's 13F filing for Q1 2023, filed 12 May 2023.